GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Other Long-Term Liabilities

Clarity Pharmaceuticals (ASX:CU6) Other Long-Term Liabilities : A$0.33 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals Other Long-Term Liabilities?

Clarity Pharmaceuticals's other long-term liabilities for the quarter that ended in Dec. 2024 was A$0.33 Mil.

Clarity Pharmaceuticals's quarterly other long-term liabilities declined from Dec. 2023 (A$0.22 Mil) to Jun. 2024 (A$0.00 Mil) but then increased from Jun. 2024 (A$0.00 Mil) to Dec. 2024 (A$0.33 Mil).

Clarity Pharmaceuticals's annual other long-term liabilities increased from Jun. 2022 (A$-0.00 Mil) to Jun. 2023 (A$0.00 Mil) and increased from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil).

Clarity Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Clarity Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Other Long-Term Liabilities Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23 Jun24
Other Long-Term Liabilities
- - -

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long-Term Liabilities Get a 7-Day Free Trial 0.10 - 0.22 - 0.33

Clarity Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Clarity Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Other Long-Term Liabilities
Comparable Companies
ASX:PYC ASX:BOT ASX:CUV ASX:IMM ASX:DXB ASX:OCC ASX:RAC ASX:IMU ASX:PAR ASX:AGN VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
CLRPF:USA
Address
4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Website
https://www.claritypharmaceuticals.com
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology. It operates as a single segment, which is Development of Radiopharmaceuticals. Geographically, it operates in Australia and the United States.

Clarity Pharmaceuticals Headlines

No Headlines